Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 11/20 | 0.38 |
| ▸ | CA1 | P00915 | 10/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 6/20 | 0.37 |
| ▸ | CA9 | Q16790 | 5/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19716620 | 0.79 | CA1 (0.50) | SYKHDAC1CA2CA1CA12 | |
| SCHEMBL23074190 | 0.77 | CA2 (0.50) | CA2CA1PPARAPPARGCA12 | |
| SCHEMBL1569930 | 0.77 | CA2 (0.56) | SYKCA2CA1CA12CA9 | |
| SCHEMBL3375330 | 0.74 | CYP17A1 (0.53) | CA2CA1PPARAPPARGCA12 | |
| SCHEMBL1726210 | 0.72 | MAPT (0.43) | SYKCA2CA1PPARAPPARG | |
| SCHEMBL1726216 | 0.72 | MAPT (0.43) | SYKCA2CA1PPARAPPARG | |
| SCHEMBL9744826 | 0.71 | HDAC3 (0.40) | HDAC1CA2CA1PPARAPPARG | |
| SCHEMBL17878732 | 0.71 | SYK (0.65) | SYKCA1PPARACA12CA7 | |
| SCHEMBL29879918 | 0.71 | SYK (0.65) | SYKCA1PPARACA12CA7 | |
| SCHEMBL5150999 | 0.71 | PTPRB (0.46) | PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5098996-A | Fluorination of compounds for use in diagnosis of nuclear medicine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-03-24 | — | — | US | disclosed |